Skip to main content

Advertisement

Log in

Vitamin D epimer: a significant bioregulator or an inactive compound?

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chailurkit L, Aekplakorn W, Ongphiphadhanakul B (2015) Serum C3 epimer of 25-hydroxyvitamin D and its determinants in adults: a national health examination survey in Thais. Osteoporos Int. Apr 14. [Epub ahead of print]

  2. Shah I, Petroczi A, Naughton DP (2014) Exploring the roles of vitamin D in Type 1 diabetes, rheumatoid arthritis, and Alzheimer Disease: new insights from accurate analysis of 10 forms. J Clin Endocrinol Metab 99:808–816

    Article  CAS  PubMed  Google Scholar 

  3. Karras SN, Shah I, Petroczi A, Goulis DG, Bili H, Papadopoulou F, Harizopoulou V, Tarlatzis BC, Naughton DP (2013) An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J 12:77

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Karras.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karras, S., Petroczi, A., Anagnostis, P. et al. Vitamin D epimer: a significant bioregulator or an inactive compound?. Osteoporos Int 26, 2345–2346 (2015). https://doi.org/10.1007/s00198-015-3198-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-015-3198-7

Keywords

Navigation